Andelyn Biosciences
Columbus, OH
Program data pending ClinicalTrials.gov matching
· Last scored 2026-10-29
63.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (20)
○ EMA GMP
○ MHRA GMP
Quick Facts: Andelyn Biosciences
- Signal Score
- 63.0/100 (as of 2026-10-29)
- Quality Compliance
- Assessment pending
- Headquarters
- Columbus, OH
- Website
- https://andelynbio.com
- Modalities
- AAV, Lentiviral, Plasmid DNA
- Active Programs
- No ClinicalTrials.gov matches confirmed — 8 partnership signals in press (announcements, not verified)
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Andelyn Biosciences
Spinout from Nationwide Children's.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 8 partnership announcements found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid DNA
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Partnership Signals (from press monitoring)
Company announcements, not verified evidence.
Financial Stability
68.0
Parent company: Nationwide Children's Hospital spinout
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Nationwide Children's Hospital spinout
Financial assessment: 68.0/100
Capacity
58.0
1 manufacturing site: Columbus, OH
Modalities: AAV, Lentiviral, Plasmid DNA
Capacity assessment: 58.0/100
Sites: Columbus, OH
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
StatusAvailable
1 manufacturing site: Columbus, OH
Modalities: AAV, Lentiviral, Plasmid DNA
Capacity assessment: 58.0/100
Sites: Columbus, OH
Press Signals20 articles (not scored)
1 manufacturing site: Columbus, OH
Modalities: AAV, Lentiviral, Plasmid DNA
Capacity assessment: 58.0/100
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Nov 20, 2026
Company Signals 20 articles
Company announcements, not verified evidence. They do not change any score.
Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies - BioSpectrum Asia
Andelyn Biosciences and PQP Group partner to streamline EU and UK supply pathways for cell and gene therapies BioSpectrum Asia
Andelyn Biosciences, PQP Partner to Streamline EU and UK Supply for CGT Sponsors - Contract Pharma
Andelyn Biosciences, PQP Partner to Streamline EU and UK Supply for CGT Sponsors Contract Pharma
Andelyn Biosciences and PQP Group Partner to Streamline EU and UK Supply Pathways for Cell and Gene Therapy Sponsors | Newswise - Newswise
Andelyn Biosciences and PQP Group Partner to Streamline EU and UK Supply Pathways for Cell and Gene Therapy Sponsors | Newswise Newswise
Andelyn Biosciences Targets Gene Therapy Growth Opportunities at ASGCT Meeting - TipRanks
Andelyn Biosciences Targets Gene Therapy Growth Opportunities at ASGCT Meeting TipRanks
ENCell signs partnership with U.S. CGT CDMO Andelyn Biosciences to build integrated production network - 더바이오
ENCell signs partnership with U.S. CGT CDMO Andelyn Biosciences to build integrated production network 더바이오
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day - TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day TipRanks
Andelyn Biosciences Highlights Engagement at Gene Therapy Symposium - TipRanks
Andelyn Biosciences Highlights Engagement at Gene Therapy Symposium TipRanks
Andelyn Biosciences Expands Global Gene Therapy Reach and Showcases Digital CDMO Capabilities - TipRanks
Andelyn Biosciences Expands Global Gene Therapy Reach and Showcases Digital CDMO Capabilities TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day - TipRanks
Andelyn Biosciences Emphasizes Gene and Cell Therapy Focus on National DNA Day TipRanks
Andelyn Biosciences Highlights Presence at Gene Therapy Symposium - TipRanks
Andelyn Biosciences Highlights Presence at Gene Therapy Symposium TipRanks
Andelyn Biosciences Highlights Transparency-Focused Dashboard for Gene Therapy CDMO Clients - TipRanks
Andelyn Biosciences Highlights Transparency-Focused Dashboard for Gene Therapy CDMO Clients TipRanks
Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact - Contract Pharma
Andelyn Biosciences, ENCell Enter Strategic Gene Therapy Manufacturing Pact Contract Pharma
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing BioSpectrum Asia
ENCell, Andelyn Biosciences partner to build global gene therapy production network - koreabiomed.com
ENCell, Andelyn Biosciences partner to build global gene therapy production network koreabiomed.com
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies - Genetic Engineering and Biotechnology News
Andelyn Partners with S. Korea-Based ENCell to Accelerate Global Delivery of Gene Therapies Genetic Engineering and Biotechnology News
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing - BioSpectrum Asia
Korea's ENCell partners with Andelyn Biosciences to expand global reach of gene therapy manufacturing BioSpectrum Asia
ENCell, Andelyn Biosciences partner to build global gene therapy production network - koreabiomed.com
ENCell, Andelyn Biosciences partner to build global gene therapy production network koreabiomed.com
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing - PR Newswire
Andelyn Biosciences and ENCell Co., Ltd Announce Strategic Partnership to Expand Global Reach of Gene Therapy Manufacturing PR Newswire
Andelyn Biosciences Sets Up US–APAC Manufacturing Bridge Through ENCell Partnership - TipRanks
Andelyn Biosciences Sets Up US–APAC Manufacturing Bridge Through ENCell Partnership TipRanks
Frequently Asked Questions About Andelyn Biosciences
What is Andelyn Biosciences's CDMO Signal Score?
Andelyn Biosciences has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating Andelyn Biosciences for a manufacturing program?
Use the free AI matchmaker to compare Andelyn Biosciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish
Oxford Biomedica
Oxford, United Kingdom
Signal Score: 76.2
Lentiviral, AAV, Plasmid DNA
Cincinnati Children's Vector Production Facility
Cincinnati, OH
Signal Score: 75.1
AAV, Lentiviral
Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Compare Andelyn Biosciences with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.